Phase 1 Study of the Safety and Pharmacokinetics of YN001 With Rosuvastatin in Healthy Chinese Subjects

Clinical trial NCT07309042 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07309042
Sponsor: Beijing Inno Medicine Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Atherosclerotic Cardiovascular Diseases Cerebrovascular Diseases

Start date: 2025-12-01
Primary completion: 2026-02-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.